BAY 41-2272, >=97% (HPLC), powder

Code: b8810-5mg D2-231

Not available outside of the UK & Ireland.

Application

BAY 41-2272 has been used for the stimulation of guanylate cyclase in heart and neurons.

Biochem/physiol Actions

BAY 41-2272 is an ac...


read more

Your Price
$274.09 5MG
REQUEST

Not available outside of the UK & Ireland.

Application

BAY 41-2272 has been used for the stimulation of guanylate cyclase in heart and neurons.

Biochem/physiol Actions

BAY 41-2272 is an activator of soluble guanylate cyclase at a novel, NO-independent regulatory site. BAY 41-2272 is the first product that stimulates sGC through a non-NO mechanism. BAY 41-2272 inhibits platelet aggregation and induces vasorelaxation without nitrate tolerance.

Features and Benefits

This compound was developed by Bayer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

5, 25 mg in glass bottle

assay≥97% (HPLC)
colorwhite to light brown
formpowder
InChI keyATOAHNRJAXSBOR-UHFFFAOYSA-N
InChI1S/C20H17FN6/c21-16-6-2-1-4-13(16)11-27-20-14(5-3-9-23-20)17(26-27)19-24-10-15(12-7-8-12)18(22)25-19/h1-6,9-10,12H,7-8,11H2,(H2,22,24,25)
mp210.5-211.4 °C
originatorBayer
Quality Level100
SMILES stringNc1nc(ncc1C2CC2)-c3nn(Cc4ccccc4F)c5ncccc35
solubilityDMSO: 5 mg/mL, clear (warmed)
storage temp.2-8°C
Code
Description
Unit Size
List Price
Qty
B8810-25MG
BAY 41-2272, >=97% (HPLC), powder

Unit:25MG
List Price: $1,003.50
Source:List Price
ADD
Cas Number256376-24-6
This product has met the following criteria: